|
|
|
|
|
|
|
31.03.26 - 13:48
|
Biogen To Acquire Apellis (AFX)
|
|
|
WESTON (dpa-AFX) - Biogen Inc. (BIIB) and Apellis Pharmaceuticals (APLS) announced they have entered into a definitive agreement under which Biogen has agreed to acquire all outstanding shares of ......
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
02.03.26 - 13:03
|
Apellis Announces Mikael Dolsten, M.D., Ph.D., to Join Board of Directors (GlobeNewswire EN)
|
|
|
WALTHAM, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that Mikael Dolsten, M.D., Ph.D., has joined the company's board of directors as of March 1. Most recently, Dr. Dolsten served for more than 16 years as chief scientific officer and president, worldwide research, development and medical, at Pfizer, during which he presided over the regulatory approval of more than 36 medicines and vaccines. ...
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|